InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
14.56
+0.09 (0.62%)
Dec 26, 2025, 1:02 PM EST - Market open
InMode Revenue
InMode had revenue of $93.17M in the quarter ending September 30, 2025, a decrease of -24.33%. This brings the company's revenue in the last twelve months to $448.03M, down -7.43% year-over-year. In the year 2024, InMode had annual revenue of $394.82M, down -19.76%.
Revenue (ttm)
$448.03M
Revenue Growth
-7.43%
P/S Ratio
2.65
Revenue / Employee
$608,504
Employees
599
Market Cap
920.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.82M | -97.23M | -19.76% |
| Dec 31, 2023 | 492.05M | 37.78M | 8.32% |
| Dec 31, 2022 | 454.27M | 96.71M | 27.05% |
| Dec 31, 2021 | 357.57M | 151.46M | 73.49% |
| Dec 31, 2020 | 206.11M | 49.75M | 31.81% |
| Dec 31, 2019 | 156.36M | 56.20M | 56.11% |
| Dec 31, 2018 | 100.16M | 46.71M | 87.37% |
| Dec 31, 2017 | 53.46M | 30.37M | 131.59% |
| Dec 31, 2016 | 23.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
INMD News
- 14 days ago - InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In - Seeking Alpha
- 7 weeks ago - InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins - PRNewsWire
- 7 weeks ago - InMode Appoints Michael Dennison as President of North America - PRNewsWire
- 2 months ago - InMode to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - InMode: Discounted Valuation & Strong Fundamentals Make It A Buy - Seeking Alpha
- 2 months ago - InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M - PRNewsWire
- 3 months ago - DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders - PRNewsWire